Toggle light / dark theme

MeiraGTx’s founders were interested in those uses; the biotech’s programs today are in diseases of the eye, salivary gland and brain.

But “we wanted to have a broader perspective on how you could potentially use gene therapy” too, CEO Alexandria Forbes says.

That vision is a high-tech, futuristic one, in which the human body can essentially become a medicine-making factory, enabled by gene therapy. But it’ll require more research, and is still years from fruition.

Read more